Page last updated: 2024-11-06

piperonyl butoxide and Nephrotic Syndrome

piperonyl butoxide has been researched along with Nephrotic Syndrome in 1 studies

Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.

Research Excerpts

ExcerptRelevanceReference
"We have recently demonstrated an important pathogenic role for glomerular catalytic iron in the puromycin aminonucleoside (PAN) induced minimal change nephrotic syndrome (MCNS)."3.71Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats. ( Baliga, R; Liu, H; Shah, SV, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, H1
Shah, SV1
Baliga, R1

Other Studies

1 other study available for piperonyl butoxide and Nephrotic Syndrome

ArticleYear
Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats.
    American journal of physiology. Renal physiology, 2001, Volume: 280, Issue:1

    Topics: Animals; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhi

2001